Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - Deutsche Boerse Ag - DE000A0JM2M1 - Common Stock - Currency: EUR

17.1  -0.2 (-1.16%)

Fundamental Rating

4

Taking everything into account, B7E scores 4 out of 10 in our fundamental rating. B7E was compared to 104 industry peers in the Capital Markets industry. Both the profitability and the financial health of B7E get a neutral evaluation. Nothing too spectacular is happening here. B7E has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year B7E has reported negative net income.
B7E had a positive operating cash flow in the past year.
Of the past 5 years B7E 4 years were profitable.
In the past 5 years B7E always reported a positive cash flow from operatings.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

1.2 Ratios

B7E has a Return On Assets (-4.39%) which is in line with its industry peers.
B7E has a Return On Equity of -13.01%. This is comparable to the rest of the industry: B7E outperforms 42.31% of its industry peers.
B7E has a better Return On Invested Capital (1.97%) than 62.50% of its industry peers.
B7E had an Average Return On Invested Capital over the past 3 years of 4.00%. This is below the industry average of 8.35%.
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROIC 1.97%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

Looking at the Operating Margin, with a value of 1.89%, B7E is in line with its industry, outperforming 58.65% of the companies in the same industry.
B7E's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 49.50%, B7E is doing good in the industry, outperforming 70.19% of the companies in the same industry.
In the last couple of years the Gross Margin of B7E has remained more or less at the same level.
Industry RankSector Rank
OM 1.89%
PM (TTM) N/A
GM 49.5%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

B7E has more shares outstanding than it did 1 year ago.
The number of shares outstanding for B7E has been increased compared to 5 years ago.
Compared to 1 year ago, B7E has a worse debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

B7E has an Altman-Z score of 1.96. This is not the best score and indicates that B7E is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.96, B7E is doing good in the industry, outperforming 72.12% of the companies in the same industry.
The Debt to FCF ratio of B7E is 7.36, which is on the high side as it means it would take B7E, 7.36 years of fcf income to pay off all of its debts.
B7E has a Debt to FCF ratio of 7.36. This is in the better half of the industry: B7E outperforms 76.92% of its industry peers.
B7E has a Debt/Equity ratio of 0.78. This is a neutral value indicating B7E is somewhat dependend on debt financing.
B7E has a Debt to Equity ratio of 0.78. This is in the better half of the industry: B7E outperforms 60.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Altman-Z 1.96
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.53 indicates that B7E should not have too much problems paying its short term obligations.
The Current ratio of B7E (1.53) is better than 75.96% of its industry peers.
A Quick Ratio of 1.08 indicates that B7E should not have too much problems paying its short term obligations.
B7E has a Quick ratio of 1.08. This is in the better half of the industry: B7E outperforms 68.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.08
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.34% over the past year.
B7E shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.57%.
Measured over the past years, B7E shows a quite strong growth in Revenue. The Revenue has been growing by 9.27% on average per year.
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%

3.2 Future

Based on estimates for the next years, B7E will show a very strong growth in Earnings Per Share. The EPS will grow by 51.47% on average per year.
B7E is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.12% yearly.
EPS Next Y669.58%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-10.78%
Revenue Next 3Y-5.7%
Revenue Next 5Y-3.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for B7E. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 19.69 indicates a rather expensive valuation of B7E.
B7E's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. B7E is cheaper than 65.38% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of B7E to the average of the S&P500 Index (21.38), we can say B7E is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 19.69
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

B7E's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. B7E is cheaper than 92.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, B7E is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.03
EV/EBITDA 4.51
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

B7E's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as B7E's earnings are expected to grow with 51.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.36%
EPS Next 3Y51.47%

More info and screens

3

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.80%.
Compared to an average industry Dividend Yield of 6.53, B7E pays a bit more dividend than its industry peers.
B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 3.8%

5.2 History

The dividend of B7E decreases each year by -14.87%.
Dividend Growth(5Y)-14.87%
Div Incr Years2
Div Non Decr Years4
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

B7E has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-46.81%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

More info and screens

BLUE CAP AG

FRA:B7E (4/25/2025, 7:00:00 PM)

17.1

-0.2 (-1.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-11 2025-03-11/amc
Earnings (Next)05-06 2025-05-06
Inst Owners25.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap76.78M
Analysts82.86
Price Target30.91 (80.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.8%
Yearly Dividend0.45
Dividend Growth(5Y)-14.87%
DP-46.81%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.26%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.69
P/S 0.3
P/FCF 6.03
P/OCF 4.14
P/B 0.95
P/tB 2.98
EV/EBITDA 4.51
EPS(TTM)-2.34
EYN/A
EPS(NY)0.87
Fwd EY5.08%
FCF(TTM)2.83
FCFY16.58%
OCF(TTM)4.13
OCFY24.17%
SpS57.27
BVpS17.92
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROCE 2.89%
ROIC 1.97%
ROICexc 2.45%
ROICexgc 4.07%
OM 1.89%
PM (TTM) N/A
GM 49.5%
FCFM 4.95%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
ROICexc(3y)4.92%
ROICexc(5y)6.13%
ROICexgc(3y)7.72%
ROICexgc(5y)7.89%
ROCE(3y)5.94%
ROCE(5y)7%
ROICexcg growth 3Y-38.65%
ROICexcg growth 5Y-19.93%
ROICexc growth 3Y-48.01%
ROICexc growth 5Y-26.87%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Debt/EBITDA 2.1
Cap/Depr 23.33%
Cap/Sales 2.27%
Interest Coverage 0.89
Cash Conversion 62.14%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.08
Altman-Z 1.96
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)27.02%
Cap/Depr(5y)44.24%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
EPS Next Y669.58%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%
Revenue Next Year-23.66%
Revenue Next 2Y-10.78%
Revenue Next 3Y-5.7%
Revenue Next 5Y-3.12%
EBIT growth 1Y-28.67%
EBIT growth 3Y-43.84%
EBIT growth 5Y-22.68%
EBIT Next Year1175.86%
EBIT Next 3Y105.41%
EBIT Next 5Y55.02%
FCF growth 1Y393.52%
FCF growth 3Y53.59%
FCF growth 5YN/A
OCF growth 1Y527.81%
OCF growth 3Y15.88%
OCF growth 5Y54.35%